Cargando…
Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma
The increasing morbidity and high mortality of intrahepatic cholangiocarcinoma (ICC) has led to the urgent need for new diagnostics and therapeutics. Liver kinase B1 (LKB1) exerts a tumor suppressor role in multiple malignances, while its regulatory role in exosomes secreted by ICC cells is obscure....
Autores principales: | Liu, Zhuo, Zhou, Kunyan, Zeng, Jian, Zhou, Xin, Li, Huanyu, Peng, Ke, Liu, Xiang, Li, Feng, Jiang, Bin, Zhao, Ming, Ma, Tiexiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350976/ https://www.ncbi.nlm.nih.gov/pubmed/35856436 http://dx.doi.org/10.3892/or.2022.8367 |
Ejemplares similares
-
Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma
por: Wang, Lei, et al.
Publicado: (2016) -
Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis
por: Xian, Feng, et al.
Publicado: (2023) -
The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma
por: Zhou, Qi, et al.
Publicado: (2013) -
Metastatic Intrahepatic Cholangiocarcinoma Presenting as an Achalasia-like Syndrome
por: Gomes, Catarina, et al.
Publicado: (2021) -
Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8(+) T-cell immune responses
por: Zhu, Ying, et al.
Publicado: (2018)